HEAD AND NECK (HNSCC)
Clinical trials for HEAD AND NECK (HNSCC) explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK (HNSCC) trials appear
Sign up with your email to follow new studies for HEAD AND NECK (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug GI-108 aims to boost immune attack on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called GI-108 in people with advanced or metastatic solid tumors (like lung, head and neck, pancreatic, or kidney cancer). The drug is designed to help the immune system fight cancer by targeting a protein called CD73 and delivering a modified immune s…
Matched conditions: HEAD AND NECK (HNSCC)
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
New pill shows promise against tough cancers
Disease control Recruiting nowThis trial tests an experimental drug called CP-383 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if CP-383 can slow or stop cancer growth and to find the safest dose. About 150 participants will take the drug daily and ha…
Matched conditions: HEAD AND NECK (HNSCC)
Phase: PHASE1, PHASE2 • Sponsor: Tasca Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Simple blood test may predict head and neck cancer behavior
Knowledge-focused Recruiting nowThis observational study aims to see if a blood test can identify the same biological tumor types as tissue analysis in people with HPV-negative head and neck cancer. About 300 adults with locally advanced, curable cancer will give blood samples before and after treatment. Resear…
Matched conditions: HEAD AND NECK (HNSCC)
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated May 18, 2026 12:07 UTC